From concept
to commercialization.
Design, engineering, capital-project execution, CQV and lifecycle delivery.
The person behind the perspectiveEngineering leadership.
Parashar Biswas (He/Him)
Engineering leadership.
Global perspective.
Senior Pharmaceutical Engineering & Capital Projects Leader. Connecting technical depth, strategic thinking and global manufacturing experience.
Director at Viatris India / Ireland
01 / Executive profileEngineering depth.
Engineering depth.
Executive perspective.
Three decades across pharmaceutical manufacturing, biotechnology and advanced drug delivery.
Parashar Biswas brings three decades of experience across pharmaceutical manufacturing, biotechnology, sterile injectables, oral solid dosage, validation science, technology transfer, combination products and commercial manufacturing.
Currently Director at Viatris, he has extensive experience leading complex pharmaceutical programs across India, Ireland and international markets. His work spans the pharmaceutical facility lifecycle: concept development, design and engineering, procurement, construction, commissioning, qualification, technology transfer, regulatory readiness and commercialization.
His leadership experience includes cross-functional teams of 20-100+ engineers, quality and operations professionals and external partners across Asia, Europe and Africa, and governance of capital portfolios exceeding $260 million.
From concept
Across borders.
Across disciplines.
Multinational project leadership across Asia, Europe and Africa within matrix organizations.
Technical decisions.
Business perspective.
Capital investment, project governance, stakeholder management, technology transfer and commercialization.
02 / Lifecycle leadershipConnecting teams.
Connecting teams.
Delivering complex programs.
Parashar works within global matrix organizations, coordinating engineering, manufacturing, quality, regulatory, technical operations, EPCM, consultants and suppliers. His background combines project governance, risk management, stakeholder alignment, vendor management and delivery performance.
His published project history includes a $50 million complex sterile injectable formulation facility, sterile oncology containment, technology transfer from India to Indonesia, pharmaceutical facilities in South Africa and Nigeria, and finished-formulation manufacturing in India.
The CV identifies major programs for 2023-2027 covering a greenfield aseptic manufacturing facility in India and GLP-1 autoinjector / combination-product activities involving India and Ireland.
Explore current & selected programs03 / Core capabilitiesSpecialist knowledge.
Specialist knowledge.
A connected perspective.
From capital planning to manufacturing technologies, with quality, collaboration and delivery at the centre.
Global engineering and capital projects
strategic capital planning, project governance, PMO, procurement, construction support, risk management and delivery assurance.
Pharmaceutical engineering
sterile injectables, aseptic manufacturing, cleanrooms, clean utilities, oncology containment, oral solid dosage and biotechnology manufacturing.
CQV and regulatory readiness
process validation, technology transfer, ASTM E2500, risk-based qualification, GMP, USFDA, EU GMP, MHRA and cGMP documentation.
Advanced drug delivery
GLP-1 manufacturing, autoinjectors, combination products, microspheres, liposomes, biosimilars and oncology.
Engineering and automation
DELTA V, process systems, equipment qualification, manufacturing technologies and digital manufacturing.
Digital transformation
AI, Industry 4.0, Digital Twins, smart manufacturing, data-driven quality, AI-enabled validation concepts and sustainability.
Leadership
multidisciplinary teams, cross-cultural collaboration, executive stakeholders, EPCM and consultant management, suppliers, CMOs and risk resolution.
See the experience
behind the expertise.
Explore the professional journey 04 / Education & developmentAlways learning.
Education, credentials & affiliations
Always learning.
Thinking ahead.
Executive and postgraduate education spans the ISB-NUS Global Advanced Management Programme, Pharmaceutical Validation Technology at Technological University Dublin, an MBA in International Business, Mechanical Engineering and Financial Management executive education at IIM Bangalore. He is also a Certified Pharmaceutical Industry Professional (CPIP), awarded by ISPE USA.
His developing areas of focus include AI-enabled pharmaceutical manufacturing, Digital Twins, Industry 4.0, digital manufacturing and sustainable pharmaceutical engineering.
ISB–NUS
Global Advanced Management Programme
TU Dublin
Pharmaceutical Validation Technology
IIM Bangalore
Financial Management · Executive Education
ISPE USA
Certified Pharmaceutical Industry Professional
05 / International experienceGlobal reach.
Global reach.
Shared purpose.
India, Ireland, Singapore, South Africa, Nigeria and Indonesia / Southeast Asia. Experience includes international project teams, consultants, EPCM organizations, CMOs, suppliers, regulatory stakeholders and cross-functional pharmaceutical organizations.
- India
- Ireland
- Singapore
- South Africa
- Nigeria
- Indonesia / Southeast Asia
Illustrative pharmaceutical engineering imagery; not photographs of Parashar or named company facilities.